Loading viewer...
investor_presentation
Format: PDF investor_presentation
Antengene Corporation Limited presents its investigational drug candidates and clinical development programs. The presentation outlines the company's pipeline and commercialization strategy across multiple therapeutic areas.
investor_presentation
68 Pages
investor_presentation
16 Pages
Pfizer
investor_presentation
8x8 Inc
Constellation Pharmaceuticals Investor Presentation — January 2020
investor_presentationinvestor_presentation
48 Pages
Constellation Pharmaceuticals
investor_presentation
Novonix